Cell & Gene: The Podcast
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
- Update frequency
- every 13 days
- Average duration
- 25 minutes
- Episodes
- 116
- Years Active
- 2021 - 2025
The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
We love to hear from our listeners. Send us a message.
Helen Sabzevari, Ph.D., President and CEO of Precigen, joins Host, Erin Harris to discuss how the company utilizes gorilla adenovirus vectors. Th…
The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan
We love to hear from our listeners. Send us a message.
Christopher Horan, Chief Technical Operations Officer, Artiva Biotherapeutics joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the ad…
Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.
We love to hear from our listeners. Send us a message.
Cell & Gene: The Podcast Host Erin Harris talks to Christopher Choi, Ph.D., MBA, SVP Industry Partnership, Director of GMP and Cell Manufacturing…
Can Gene Therapy Be the Solution for CHF with AskBio's Dr. Lothar Roessig
We love to hear from our listeners. Send us a message.
Cell & Gene: The Podcast Host Erin Harris talks to Lothar Roessig, M.D., SVP, Integrated Product Team Lead, Congestive Heart Failure at Asklepios…
Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rahkit
We love to hear from our listeners. Send us a message.
On this episode of Cell & Gene: The Podcast, Host Erin Harris, invites BlueRock Therapeutics' Dr. Amit Rhakit to take a deep dive into therapy op…
Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene
We love to hear from our listeners. Send us a message.
Rita Johnson-Greene, COO at Alliance for Regenerative Medicine (ARM) joined Cell & Gene: The Podcast Host, Erin Harris, on site during 2024 Meeti…
Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams
We love to hear from our listeners. Send us a message.
On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Dennis Williams, Senior Vice President of Late Stage Development at Adapti…
Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte
We love to hear from our listeners. Send us a message.
This episode of Cell & Gene: The Podcast was recorded on site during ARM's 2024 Meeting on the Mesa in Phoenix. Tune in to hear Host Erin Harris …
Pioneering Next-Gen TCR Therapies in Solid Tumors with Neogene Therapeutics’ Carsten Linnemann, Ph.D.
We love to hear from our listeners. Send us a message.
Carsten Linnemann, Ph.D., CEO of Neogene Therapeutics and Head of Oncology Cell Therapy Clinical Development, AstraZeneca joins Cell & Gene: The …
Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge
We love to hear from our listeners. Send us a message.
Ray Therapeutics' Co-Founder and CEO, Paul Bresge, joins Host Erin Harris to talk about optogenetics and how the company’s optogenetics approach …
A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino
We love to hear from our listeners. Send us a message.
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that…
Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts
We love to hear from our listeners. Send us a message.
Allogene Therapeutics' EVP of R&D and CMO, Dr. Zachary Roberts, penned an original article for Cell & Gene titled, The Path Forward for CLL is Al…
CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.
We love to hear from our listeners. Send us a message.
Applications (BLAs) of recent approvals and complete responses for novel products or rare diseases as well as BLAs currently under review. Benton…
Identifying Drug Development Opportunities for DMD with CureDuchenne
We love to hear from our listeners. Send us a message.
Debra Miller, CEO and Founder and Dr. Michael Kelly, Chief Scientific Officer at CureDuchenne talk to Host Erin Harris about the FDA approval for…
Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington
We love to hear from our listeners. Send us a message.
Lucas Harrington, Co-Founder and Chief Scientific Officer of Mammoth Biosciences, joins Erin Harris to shed light on the biotech's proprietary ul…
TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.
We love to hear from our listeners. Send us a message.
KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Erin Harris to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have t…
Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft
We love to hear from our listeners. Send us a message.
Strand Therapeutics' CEO and Co-Founder Jake Becraft joins Erin Harris to discuss genetic regulation and how the company's programmable mRNA cons…
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skippin…
The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley
We love to hear from our listeners. Send us a message.
Dr. Bambi Grilley is Professor of Pediatrics and the Director of Clinical Research and Early Product Development for the Center of Cell and Gene …
Dr. Bruce Levine on ISCT and the Future of CAR-T
We love to hear from our listeners. Send us a message.
In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as w…